Lyra Therapeutics (LYRA) says ENLIGHTEN 1 trial did not meet its primary endpoint

Visit StreetInsider.com at http://www.streetinsider.com/Trading+Halts/Lyra+Therapeutics+%28LYRA%29+says+ENLIGHTEN+1+trial+did+not+meet+its+primary+endpoint/23175527.html for the full story.